Delivery Order SPE2DB24D3013-SPE2DB25FFQPS
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $9.36K to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a widely prescribed anticoagulant medication. The order, issued on August 15, 2025, with completion targeted for August 18, 2025, represents a firm fixed-price delivery under a non-set-aside, competitively awarded procurement. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency awarded a delivery order valued at $15,614.63 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a widely used anticoagulant medication. The contract, executed on August 25, 2025, with completion scheduled for August 26, 2025, operates under firm fixed pricing with no set-aside designation. Performance of this delivery order is based in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters as a major pharmaceutical...
- The Defense Logistics Agency awarded a $37,391.10 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a commonly prescribed anticoagulant medication. This contract, effective June 2–3, 2025, was competitively awarded without set-aside provisions and carries firm fixed pricing. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order valued at $17,868.41 to AmerisourceBergen Drug Corp for 60-tablet bottles of Eliquis 5 mg, a prescription anticoagulant medication. This non-set-aside, competitively awarded contract utilized firm fixed pricing and was completed on June 5, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a $9,564.78 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a widely prescribed anticoagulant medication. The contract was competitively awarded without set-aside provisions and is scheduled for completion by May 20, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and...
- The Defense Logistics Agency (DLA) awarded a $9,868.31 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a commonly prescribed anticoagulant medication. This competitive delivery order, issued on August 11, 2025, with an ultimate completion date of August 12, 2025, carries firm fixed pricing and represents a child contract under AmerisourceBergen's broader pharmaceutical supply vehicle with DLA. The place of performance is AmerisourceBergen's corporate office location...
- The Defense Logistics Agency awarded a delivery order valued at $2,629.78 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a prescription anticoagulant medication. The contract was executed on August 13, 2025, with an ultimate completion date of August 14, 2025, utilizing firm fixed-price pricing with no set-aside designation. Performance will occur at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order was issued under AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $9,484.04 to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a widely prescribed anticoagulant medication. This non-set-aside contract was competitively awarded on August 13, 2025, with an ultimate completion date of August 14, 2025. The contract employs firm fixed pricing and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $15,808.62 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Eliquis 5 mg, a commonly prescribed anticoagulant medication. The contract was executed on August 13, 2025, with an ultimate completion date of August 14, 2025, and carries firm fixed pricing under a non-set-aside competitive award. Performance of the contract is based in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $10,100.34 for 60 tablets of Eliquis 5 mg, a widely prescribed anticoagulant medication. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is scheduled for completion by August 22, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical...
- SPE2DB24D3013Indefinite Delivery Contract
- SPE2DB24D3013-SPE2DB25FFQPSDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $9,960.98 to AmerisourceBergen Drug Corp for 60-tablet bottles of Eliquis 5 mg, a leading anticoagulant medication. The contract, awarded September 15, 2025, with completion due September 16, 2025, utilizes firm fixed pricing with no small business set-aside. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the place of performance and brings substantial pharmaceutical distribution capabilities to federal medical procurement operations. This delivery order operates under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This prime vendor vehicle enables AmerisourceBergen to supply comprehensive pharmaceutical products and medical supplies supporting military healthcare systems globally. The arrangement reflects DLA's reliance on major pharmaceutical distributors to fulfill critical medication requirements across the defense medical supply chain, including support for the Defense Health Agency and other federal healthcare entities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.0k | 9/15/25 |